Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present DanDrit Biotech USA, Inc. (OTC: DDRT).

Full DD Report for DDRT

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-03-196.006.056.056.0030,875
2018-03-186.006.056.056.0030,875
2018-03-176.006.056.056.0030,875
2018-03-166.006.056.056.0030,875
2018-03-155.306.006.005.3011,600

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-03-169,90930,87532.0939Cover
2018-03-154,70011,60040.5172Short
2018-03-1414,42023,64860.9777Short
2018-03-123,0204,22071.5640Short
2018-03-0913,66020,06068.0957Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on DDRT.


About DanDrit Biotech USA, Inc. (OTC: DDRT)

Logo for DanDrit Biotech USA, Inc. (OTC: DDRT)

We are a US based clinical stage company developing new approaches to leverage the immune system to fight cancers and infectious diseases. Our vision is to radically improve outcomes for patients with unmet needs in HIV/AIDS and oncology. Our intent is to develop transformative, multi indication, platform drugs that harness the power of immunotherapy and change the standards of care of AIDS and cancer. We will expedite programs to market through strategic development and leveraging enhanced FDA programs and corporate partnerships.

 

Contact Information

 

 

Current Management

  • Eric Leire / CEO
    • MD, MBA
  • Robert E. Wolfe / CFO
  • Evelyn D An / Independent Director
  • Mark R. Dybul /
  • Henrik GronfeldtSorensen /
  • Eric Leire / MD, MBA
  • Carl Sandler /
  • James Sapirstein / Independent Director
  • Rene Sindlev /
  • Robert E. Wolfe /

Current Share Structure

  • Market Cap: $93,898,535 - 03/09/2018
  • Authorized: 100,000,000 - 09/28/2017
  • Issue and Outstanding: 13,910,894 - 02/07/2018
  • Float: 7,402,528 - 09/28/2017

 


Recent Filings from (OTC: DDRT)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 23 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 18 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 17 2018
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: January, 02 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: November, 20 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 20 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 17 2017
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: November, 15 2017

 

 


Daily Technical Chart for (OTC: DDRT)

Daily Technical Chart for (OTC: DDRT)


Stay tuned for daily updates and more on (OTC: DDRT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: DDRT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in DDRT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of DDRT and does not buy, sell, or trade any shares of DDRT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/